ARCHIVES

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

This article is from The Cancer Letter archive.

Vol. 37 No. 15 | April 15, 2011

Download PDF Visit The Full Archive

Related Articles

Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes

February 5, 1982

In congress: Senate Committee Approves 7.5 Percent Increase for NIH

July 25, 1997

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements.

June 20, 2003

NCAB Discussion Of Working Group Report

February 28, 2003

NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive

May 10, 1996